Literature DB >> 27763634

Phenotypic predictors and final diagnoses in patients referred for RASopathy testing by targeted next-generation sequencing.

Elizabeth J Bhoj1,2, Zhenming Yu1, Qiaoning Guan1, Rebecca Ahrens-Nicklas2, Kajia Cao1, Minjie Luo1,3, Tanya Tischler1, Matthew A Deardorff2,3, Elaine Zackai2,3, Avni B Santani1,3.   

Abstract

INTRODUCTION: RASopathies include disorders generally characterized by developmental delay, specific heart defects, short stature, cardiac hypertrophy, and facial dysmorphisms. Next-generation sequencing (NGS)-based panels have widespread acceptance as a diagnostic tool for RASopathies.
MATERIALS AND METHODS: The first 126 patients evaluated by clinical examination and the NGS RASopathy panel at the Children's Hospital of Philadelphia were enrolled. We calculated diagnosis rate, correlated reported clinical findings with positive or negative test results, and identified final molecular diagnoses in 28/96 patients who tested negative for RASopathies.
RESULTS: Twenty-four patients had pathogenic variants on the RASopathy panel, for a diagnostic yield of 19%. Reported features of pulmonic stenosis and ptosis were significantly correlated with a positive test result; no reported features were significantly correlated with a negative test result. We identified 27 different alternative diagnoses for patients originally suspected of having RASopathies. DISCUSSION: This study provides information that can assist in guiding differential diagnosis and genetic testing for patients suspected of having a RASopathy disorder.Genet Med advance online publication 20 October 2016.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27763634      PMCID: PMC6095193          DOI: 10.1038/gim.2016.169

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  10 in total

Review 1.  Noonan syndrome: clinical features, diagnosis, and management guidelines.

Authors:  Alicia A Romano; Judith E Allanson; Jovanna Dahlgren; Bruce D Gelb; Bryan Hall; Mary Ella Pierpont; Amy E Roberts; Wanda Robinson; Clifford M Takemoto; Jacqueline A Noonan
Journal:  Pediatrics       Date:  2010-09-27       Impact factor: 7.124

2.  Gain-of-function mutations in RIT1 cause Noonan syndrome, a RAS/MAPK pathway syndrome.

Authors:  Yoko Aoki; Tetsuya Niihori; Toshihiro Banjo; Nobuhiko Okamoto; Seiji Mizuno; Kenji Kurosawa; Tsutomu Ogata; Fumio Takada; Michihiro Yano; Toru Ando; Tadataka Hoshika; Christopher Barnett; Hirofumi Ohashi; Hiroshi Kawame; Tomonobu Hasegawa; Takahiro Okutani; Tatsuo Nagashima; Satoshi Hasegawa; Ryo Funayama; Takeshi Nagashima; Keiko Nakayama; Shin-Ichi Inoue; Yusuke Watanabe; Toshihiko Ogura; Yoichi Matsubara
Journal:  Am J Hum Genet       Date:  2013-06-20       Impact factor: 11.025

3.  Novel association of neurofibromatosis type 1-causing mutations in families with neurofibromatosis-Noonan syndrome.

Authors:  Sara Ekvall; Kerstin Sjörs; Anders Jonzon; Mauno Vihinen; Göran Annerén; Marie-Louise Bondeson
Journal:  Am J Med Genet A       Date:  2013-12-19       Impact factor: 2.802

4.  Next-generation sequencing identifies rare variants associated with Noonan syndrome.

Authors:  Peng-Chieh Chen; Jiani Yin; Hui-Wen Yu; Tao Yuan; Minerva Fernandez; Christina K Yung; Quang M Trinh; Vanya D Peltekova; Jeffrey G Reid; Erica Tworog-Dube; Margaret B Morgan; Donna M Muzny; Lincoln Stein; John D McPherson; Amy E Roberts; Richard A Gibbs; Benjamin G Neel; Raju Kucherlapati
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-21       Impact factor: 11.205

5.  Heterozygous germline mutations in the CBL tumor-suppressor gene cause a Noonan syndrome-like phenotype.

Authors:  Simone Martinelli; Alessandro De Luca; Emilia Stellacci; Cesare Rossi; Saula Checquolo; Francesca Lepri; Viviana Caputo; Marianna Silvano; Francesco Buscherini; Federica Consoli; Grazia Ferrara; Maria C Digilio; Maria L Cavaliere; Johanna M van Hagen; Giuseppe Zampino; Ineke van der Burgt; Giovanni B Ferrero; Laura Mazzanti; Isabella Screpanti; Helger G Yntema; Willy M Nillesen; Ravi Savarirayan; Martin Zenker; Bruno Dallapiccola; Bruce D Gelb; Marco Tartaglia
Journal:  Am J Hum Genet       Date:  2010-07-08       Impact factor: 11.025

6.  A novel rasopathy caused by recurrent de novo missense mutations in PPP1CB closely resembles Noonan syndrome with loose anagen hair.

Authors:  Karen W Gripp; Kimberly A Aldinger; James T Bennett; Laura Baker; Jessica Tusi; Nina Powell-Hamilton; Deborah Stabley; Katia Sol-Church; Andrew E Timms; William B Dobyns
Journal:  Am J Med Genet A       Date:  2016-06-05       Impact factor: 2.802

7.  Activating Mutations Affecting the Dbl Homology Domain of SOS2 Cause Noonan Syndrome.

Authors:  Viviana Cordeddu; Jiani C Yin; Cecilia Gunnarsson; Carl Virtanen; Séverine Drunat; Francesca Lepri; Alessandro De Luca; Cesare Rossi; Andrea Ciolfi; Trevor J Pugh; Alessandro Bruselles; James R Priest; Len A Pennacchio; Zhibin Lu; Arnavaz Danesh; Rene Quevedo; Alaa Hamid; Simone Martinelli; Francesca Pantaleoni; Maria Gnazzo; Paola Daniele; Christina Lissewski; Gianfranco Bocchinfuso; Lorenzo Stella; Sylvie Odent; Nicole Philip; Laurence Faivre; Marketa Vlckova; Eva Seemanova; Cristina Digilio; Martin Zenker; Giuseppe Zampino; Alain Verloes; Bruno Dallapiccola; Amy E Roberts; Hélène Cavé; Bruce D Gelb; Benjamin G Neel; Marco Tartaglia
Journal:  Hum Mutat       Date:  2015-08-03       Impact factor: 4.878

8.  NF1 gene mutations represent the major molecular event underlying neurofibromatosis-Noonan syndrome.

Authors:  Alessandro De Luca; Irene Bottillo; Anna Sarkozy; Claudio Carta; Cinzia Neri; Emanuele Bellacchio; Annalisa Schirinzi; Emanuela Conti; Giuseppe Zampino; Agatino Battaglia; Silvia Majore; Maria M Rinaldi; Massimo Carella; Bruno Marino; Antonio Pizzuti; Maria Cristina Digilio; Marco Tartaglia; Bruno Dallapiccola
Journal:  Am J Hum Genet       Date:  2005-10-26       Impact factor: 11.025

Review 9.  Noonan syndrome.

Authors:  Ineke van der Burgt
Journal:  Orphanet J Rare Dis       Date:  2007-01-14       Impact factor: 4.123

10.  Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Authors:  Sue Richards; Nazneen Aziz; Sherri Bale; David Bick; Soma Das; Julie Gastier-Foster; Wayne W Grody; Madhuri Hegde; Elaine Lyon; Elaine Spector; Karl Voelkerding; Heidi L Rehm
Journal:  Genet Med       Date:  2015-03-05       Impact factor: 8.822

  10 in total
  4 in total

Review 1.  The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.

Authors:  Joseph D Khoury; Eric Solary; Oussama Abla; Yassmine Akkari; Rita Alaggio; Jane F Apperley; Rafael Bejar; Emilio Berti; Lambert Busque; John K C Chan; Weina Chen; Xueyan Chen; Wee-Joo Chng; John K Choi; Isabel Colmenero; Sarah E Coupland; Nicholas C P Cross; Daphne De Jong; M Tarek Elghetany; Emiko Takahashi; Jean-Francois Emile; Judith Ferry; Linda Fogelstrand; Michaela Fontenay; Ulrich Germing; Sumeet Gujral; Torsten Haferlach; Claire Harrison; Jennelle C Hodge; Shimin Hu; Joop H Jansen; Rashmi Kanagal-Shamanna; Hagop M Kantarjian; Christian P Kratz; Xiao-Qiu Li; Megan S Lim; Keith Loeb; Sanam Loghavi; Andrea Marcogliese; Soheil Meshinchi; Phillip Michaels; Kikkeri N Naresh; Yasodha Natkunam; Reza Nejati; German Ott; Eric Padron; Keyur P Patel; Nikhil Patkar; Jennifer Picarsic; Uwe Platzbecker; Irene Roberts; Anna Schuh; William Sewell; Reiner Siebert; Prashant Tembhare; Jeffrey Tyner; Srdan Verstovsek; Wei Wang; Brent Wood; Wenbin Xiao; Cecilia Yeung; Andreas Hochhaus
Journal:  Leukemia       Date:  2022-06-22       Impact factor: 12.883

2.  Comprehensive Genetic Analysis of RASopathy in the Era of Next-Generation Sequencing and Definition of a Novel Likely Pathogenic >KRAS Variation.

Authors:  Selma Demir; Hümeyra Yaşar Köstek; Aslıhan Sanrı; Ruken Yıldırım; Fatma Özgüç Çömlek; Sinem Yalçıntepe; Murat Deveci; Emine İkbal Atlı; Engin Atlı; Damla Eker; Hakan Gürkan; Filiz Tütüncüler Kökenli
Journal:  Mol Syndromol       Date:  2022-01-07

3.  Congenital polyvalvular disease expands the cardiac phenotype of the RASopathies.

Authors:  Dena R Matalon; David A Stevenson; Elizabeth J Bhoj; Avni B Santani; Beth Keena; Meryl S Cohen; Angela E Lin; Sarah E Sheppard; Elaine H Zackai
Journal:  Am J Med Genet A       Date:  2021-03-08       Impact factor: 2.802

Review 4.  Cutaneous neurofibromas in the genomics era: current understanding and open questions.

Authors:  Robert J Allaway; Sara J C Gosline; Salvatore La Rosa; Pamela Knight; Annette Bakker; Justin Guinney; Lu Q Le
Journal:  Br J Cancer       Date:  2018-04-26       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.